최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Alimentary pharmacology & therapeutics, v.14 no.12, 2000년, pp.1561 - 1565
Boulton‐Jones, J. R. , Pritchard, K. , Mahmoud, A. A.
Introduction:Azathioprine is a useful therapy in patients with inflammatory bowel disease that is difficult to control. However, 10% of patients are unable to tolerate azathioprine, and the best form of treatment for this group of patients is unknown. The azathioprine metabolite 6‐mercaptopur...
Am J Gastroenterol Alder DJ 717 85 1990 The therapeutic efficacy of 6‐mercaptopurine in refractory ulcerative colitis
Present, Daniel H., Korelitz, Burton I., Wisch, Nathaniel, Glass, Joseph L., Sachar, David B., Pasternack, Bernard S.. Treatment of Crohn's Disease with 6-Mercaptopurine : A Long-Term, Randomized, Double-Blind Study. The New England journal of medicine, vol.302, no.18, 981-987.
Pearson, David C.. Azathioprine and 6-Mercaptopurine in Crohn Disease : A Meta-Analysis. Annals of internal medicine, vol.123, no.2, 132-.
Present, Daniel H.. 6-Mercaptopurine in the Management of Inflammatory Bowel Disease: Short- and Long-Term Toxicity. Annals of internal medicine, vol.111, no.8, 641-.
O'Brien, John J., Bayless, Theodore M., Bayless, Jeffrey A.. Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease. Gastroenterology, vol.101, no.1, 39-46.
Korelitz, Burton I., Zlatanic, Jusuf, Goel, Freesia, Fuller, Steven. Allergic Reactions to 6-Mercaptopurine During Treatment of Inflammatory Bowel Disease :. Journal of clinical gastroenterology, vol.28, no.4, 341-344.
British National Formulary 38.Section 8.2.1.1999: 388.
Connell, W R, Kamm, M A, Ritchie, J K, Lennard-Jones, J E. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.. Gut: journal of the British Society of Gastroenterology, vol.34, no.8, 1081-1085.
Ann New York Acad Sci Elion GB 400 685 1993 10.1111/j.1749-6632.1993.tb35897.x The pharmacology of azathioprine
Bouhnik, Y, Scemama, G, Taï, R, Matuchansky, C, Rambaud, J-C, Lémann, M, Modigliani, R, Mary, J-Y. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. The Lancet, vol.347, no.8996, 215-219.
Gastroenterology Lemann M A1025 112 1997 Treatment of Crohn’s disease (CD) with 6‐mercaptopurine (6‐MP) in patients intolerant to azathioprine (AZA)
Calne, R. Y., Alexandre, G. P. J., Murray, J. E.. A STUDY OF THE EFFECTS OF DRUGS IN PROLONGING SURVIVAL OF HOMOLOGOUS RENAL TRANSPLANTS IN DOGS*. Annals of the New York Academy of Sciences, vol.99, no.3, 743-761.
Krenitsky, Thomas A., Hall, Willard W., Selph, Jeffrey L., Truax, James F., Vinegar, Ralph. Nucleosides of azathioprine and thiamiprine as antiarthritics. Journal of medicinal chemistry, vol.32, no.7, 1471-1475.
Mahmoud, AEA, Willoughby, JMT. Azathioprine and 6-mercaptopurine are not necessarily interchangeable in the treatment of Crohn's disease. Gastroenterology, vol.108, no.4, A868-A868.
Pratt, DS, Flavin, DP, Kaplan, MM. The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine. Gastroenterology, vol.110, no.1, 271-274.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.